Kuur Therapeutics

BiotechnologySeries CLondon, UKkuurtx.com

Latest round

Series C

Last raised

Mar 2017

Total raised

$166M

Investors

4

About Kuur Therapeutics

Founded in 2005, Kuur Therapeutics focuses on developing cell therapy solutions for cancer treatment. The company was acquired by Athenex, Inc.Kuur Therapeutics delivers advanced cell therapy solutions targeted at improving cancer treatment. Their core offerings include innovative therapeutics designed to enhance patient outcomes by harnessing the body’s immune system.7.Moving forward, Kuur Therapeutics plans to leverage the recent acquisition to enhance its cell therapy development capabilities. The company aims to penetrate new markets, particularly within North America and Europe, by 2025 to broaden access to its innovative therapies.

Who invested in Kuur Therapeutics

4 investors across 3 rounds

See all investors in Kuur Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Mar 15, 2017

    Amount

    $74M

    Investors

    Locked

  2. Series B

    Nov 24, 2014

    Amount

    $79M

    Investors

    Locked

  3. Series A

    Jul 19, 2013

    Amount

    $13M

    Investors

    Locked

Questions about Kuur Therapeutics

Who invested in Kuur Therapeutics?

Kuur Therapeutics has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Kuur Therapeutics raised?

Kuur Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Kuur Therapeutics last raise money?

Kuur Therapeutics's most recent round on record is a Series C, in Mar 2017.

What does Kuur Therapeutics do?

Founded in 2005, Kuur Therapeutics focuses on developing cell therapy solutions for cancer treatment.

Where is Kuur Therapeutics headquartered?

Kuur Therapeutics is headquartered in London, UK.

Which VCs invest in companies like Kuur Therapeutics?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Kuur Therapeutics's stage. Their profiles are linked below.

Raising like Kuur Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.